Literature DB >> 2990386

Molecular cloning and partial characterization of the coxsackievirus B3 genome. Brief report.

S Tracy, N M Chapman, H L Liu.   

Abstract

The RNA genome of coxsackievirus B3 has been cloned and partially characterized by restriction mapping, partial sequence analysis, and hybridization to heterologous coxsackievirus B genomes. It differs significantly from the poliovirus genomic structure.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2990386     DOI： 10.1007/bf01317016

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  21 in total

1.  Sequence of picornavirus RNAs containing a radioiodinated 5'-linked peptide reveals a conserved 5' sequence.

Authors:  M J Hewlett; R Z Florkiewicz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

2.  Reverse transcriptase and its associated ribonuclease H: interplay of two enzyme activities controls the yield of single-stranded complementary deoxyribonucleic acid.

Authors:  S L Berger; D M Wallace; R S Puskas; W H Eschenfeldt
Journal:  Biochemistry       Date:  1983-05-10       Impact factor: 3.162

3.  Translation of coxsackievirus B RNAs in a rabbit reticulocyte lysate: characterization of the genome RNA, reaction conditions for translation, and analysis of the products.

Authors:  N K Chatterjee; C Tuchowski
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

5.  Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA.

Authors:  G R Larsen; B L Semler; E Wimmer
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

6.  Detection of enteroviruses by spot hybridization.

Authors:  T Hyypiä; P Stålhandske; R Vainionpää; U Pettersson
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

7.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  Nature       Date:  1983 Aug 25-31       Impact factor: 49.962

8.  Terminal transferase-catalyzed addition of nucleotides to the 3' termini of DNA.

Authors:  R Roychoudhury; R Wu
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

9.  The nucleotide sequence at the 5' end of foot and mouth disease virus RNA.

Authors:  T J Harris
Journal:  Nucleic Acids Res       Date:  1979-12-11       Impact factor: 16.971

10.  Poliovirus type 3: molecular cloning of the genome and nucleotide sequence of the region encoding the protease and polymerase proteins.

Authors:  A J Cann; G Stanway; R Hauptmann; P D Minor; G C Schild; L D Clarke; R C Mountford; J W Almond
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971
View more
  11 in total

1.  Chimeric picornavirus polyproteins demonstrate a common 3C proteinase substrate specificity.

Authors:  P G Dewalt; M A Lawson; R J Colonno; B L Semler
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

2.  A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive.

Authors:  B L Semler; V H Johnson; S Tracy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 4.  Link between enteroviruses and dilated cardiomyopathy: serological and molecular data.

Authors:  P J Keeling; S Tracy
Journal:  Br Heart J       Date:  1994-12

5.  Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s).

Authors:  M A Beck; S M Tracy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Enteroviral infection in end stage dilated cardiomyopathy.

Authors:  V Wiegand; S Tracy; N Chapman; C Wucherpfennig
Journal:  Klin Wochenschr       Date:  1990-09-14

7.  Echovirus 22 is an atypical enterovirus.

Authors:  B A Coller; N M Chapman; M A Beck; M A Pallansch; C J Gauntt; S M Tracy
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  A group B coxsackievirus/poliovirus 5' nontranslated region chimera can act as an attenuated vaccine strain in mice.

Authors:  N M Chapman; A Ragland; J S Leser; K Höfling; S Willian; B L Semler; S Tracy
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice.

Authors:  S Tracy; N M Chapman; Z Tu
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

10.  The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.

Authors:  Z Tu; N M Chapman; G Hufnagel; S Tracy; J R Romero; W H Barry; L Zhao; K Currey; B Shapiro
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.